LGMN and Alzheimer disease: A recent study revealed that CCAAT enhancer-binding protein β (C/EBPβ) plays a key role in the pathogenesis of AD by increasing the expression of asparagine endopeptidase (AEP), and further proposed to activate C/EBPβ/ AEP signaling pathway can mediate AD [44].